All 1 tracked stories fall under one category: pharma. CSL Limited is most often covered alongside Australia, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about CSL Limited
All 1 tracked stories fall under one category: pharma. CSL Limited is most often covered alongside Australia, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. Their average consequence score of 7 runs above the beat's 5.9 for that window. We currently track 1 Biotech story that mention CSL Limited, all published on March 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering CSL Limited. Shared-story counts are live from our verified record — not editorial picks.
After eight years of complex negotiations, the European Union and Australia have signed a landmark free trade agreement aimed at eliminating regulatory barriers. The deal is set to streamline market access for European biologics while securing critical mineral supply chains essential for advanced medical manufacturing.
CSL Limited is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.